New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation

DQ Group Author

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Two new tris-hydroxypyridinone based compounds (KEMPPr(3,4-HP)(3) and KEMPBu(3,4-HP)(3)) have been developed and studied as strong sequestering agents for iron and the group III of metal ions, aimed as potential pharmacological applications on metal-chelation therapy. Their structure is based on the KEMP acid scaffold to which three 3-hydroxy-4-pyridinone chelating moieties are attached via two different size spacers. After the preparation and characterization of the compounds their physico-chemical properties were studied, in relation with their metal binding affinity and lipophilicity. The KEMPPr(3,4-HP)(3) ligand was also bioassayed to evaluate its in vivo metal sequestering capacity from most organs using an Ga-67 for both in solution and in vivo conditions, animal model overload with. These studies showed that, the compounds have higher metal chelating efficacy than Deferriprone, the commercially available iron chelator in medical application, thus some perspectives are envisaged as potential pharmaceutical drug candidates for chelating therapy. (C) 2008 Elsevier Inc. All rights reserved.
Original languageEnglish
Pages (from-to)262-273
JournalJournal of Inorganic Biochemistry
Volume103
Issue number2
Publication statusPublished - 1 Jan 2009

Fingerprint Dive into the research topics of 'New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation'. Together they form a unique fingerprint.

  • Cite this